Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. agilon health inc. shares valued at $186,791 were sold by Kornitzer Benjamin on Sep 09. At $23.08 per share, Kornitzer Benjamin sold 8,094 shares. The insider’s holdings dropped to 10,853 shares worth approximately $0.26 million following the completion of this transaction.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now.
Also, Kornitzer Benjamin sold 13,490 shares, netting a total of over 305,676 in proceeds. Following the sale of shares at $22.66 each, the insider now holds 10,853 shares.
Before that, Kornitzer Benjamin had sold 5,396 shares from its account. In a trade valued at $112,775, the Chief Med. & Quality Officer traded agilon health inc. shares for $20.90 each. Upon closing the transaction, the insider’s holdings decreased to 5,396 shares, worth approximately $0.26 million.
As published in their initiating research note from RBC Capital Mkts on September 14, 2022, agilon health inc. [AGL] has been an Outperform and the price target has been revised to $33. This represents a 28.76% premium over Wednesday’s closing price. Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in mid September. Earlier on June 24, 2022, BTIG Research initiated its rating. Their recommendation was “a Neutral” for AGL stock.
Analyzing AGL’s Price Performance
On Wednesday, agilon health inc. [NYSE: AGL] rose 0.04% to $23.51. The stock’s lowest price that day was $23.40, but it reached a high of $24.17 in the same session. During the last five days, there has been a drop of approximately -4.28%. Over the course of the year, agilon health inc. shares have dropped approximately -12.93%. Shares of the company reached a 52-week high of $28.36 on 07/21/22 and a 52-week low of $14.36 on 01/28/22. A 50-day SMA is recorded $23.92, while a 200-day SMA reached $21.87. Nevertheless, trading volume fell to 1.53 million shares from 1.73 million shares the previous day.
Support And Resistance Levels for agilon health inc. (AGL)
According to the 24-hour chart, there is a support level at 23.22, which, if violated, would cause prices to drop to 22.92. In the upper region, resistance lies at 23.99. The next price resistance is at 24.46. RSI (Relative Strength Index) is 52.07 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.38, which suggests the price will decrease in the coming days. Percent R is at 35.10%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is agilon health inc. subject to short interest?
Stocks of agilon health inc. saw a sharp rise in short interest on Aug 30, 2022 jumping by 1.79 million shares to 21.29 million. Data from Yahoo Finance shows that the short interest on Jul 28, 2022 was 19.5 million shares. A jump of 8.41% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.23 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.23.
Which companies own the most shares of agilon health inc. (AGL)?
According to Morgan Stanley Investment Managem filings, the company currently owns 42,091,022 shares, which is about 10.24% of the total AGL shares outstanding. The investor’s shares have appreciated by 7,156,370 from its previous 13-F filing of 34934652.0 shares. With the completion of the sale transaction, Capital Research & Management Co’s stake is now worth $693,246,297. Fidelity Management & Research Co acquire a 8.99% interest valued at $656.05 million while Wellington Management Co. LLP purchased a 1,796,935 stake. A total of 2,989,699 shares of agilon health inc. were bought by The Vanguard Group, Inc. during the quarter, and -1,221,665 were sold by Capital Research & Management Co. In its current portfolio, Rock Springs Capital Management L holds 7,681,000 shares valued at $159.61 million.
In terms of agilon health inc. share price expectations, FactSet research, analysts set an average price target of $32.67 in the next 12 months, up nearly 38.3% from the previous closing price of $23.50. Analysts anticipate agilon health inc. stock to reach $41.00 by 2022, with the lowest price target being $26.00. In spite of this, 14 analysts ranked agilon health inc. stock as a Buy at the end of 2022. On March 30, 2022, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $32.